94 related articles for article (PubMed ID: 24506837)
1. Pharmacokinetic interaction between febuxostat and morin in rats.
Sahu K; Siddiqui AA; Shaharyar M; Malik S
Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):307-12. PubMed ID: 24506837
[TBL] [Abstract][Full Text] [Related]
2. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
Choi BC; Choi JS; Han HK
Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
Pathak SM; Udupa N
Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
[TBL] [Abstract][Full Text] [Related]
4. Effect of morin on pharmacokinetics of piracetam in rats, in vitro enzyme kinetics and metabolic stability assay using rapid UPLC method.
Sahu K; Shaharyar M; Siddiqui AA
Drug Test Anal; 2013 Jul; 5(7):581-8. PubMed ID: 22740350
[TBL] [Abstract][Full Text] [Related]
5. Effects of morin on the pharmacokinetics of etoposide in rats.
Li X; Yun JK; Choi JS
Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
[TBL] [Abstract][Full Text] [Related]
6. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
Choi HJ; Choi JS
Arch Pharm Res; 2005 Aug; 28(8):970-6. PubMed ID: 16178425
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats.
Choi JS; Han HK
Pharmacol Res; 2005 Nov; 52(5):386-91. PubMed ID: 16002304
[TBL] [Abstract][Full Text] [Related]
8. Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats.
Choi YA; Yoon YH; Choi K; Kwon M; Goo SH; Cha JS; Choi MK; Lee HS; Song IS
Biol Pharm Bull; 2015; 38(2):208-17. PubMed ID: 25747979
[TBL] [Abstract][Full Text] [Related]
9. Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.
Piao YJ; Choi JS
J Pharm Pharmacol; 2008 May; 60(5):625-9. PubMed ID: 18416939
[TBL] [Abstract][Full Text] [Related]
10. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH
Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773
[TBL] [Abstract][Full Text] [Related]
11. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
Shin SC; Piao YJ; Choi JS
In Vivo; 2008; 22(3):391-5. PubMed ID: 18610753
[TBL] [Abstract][Full Text] [Related]
12. Enhanced systemic availability of methotrexate in the presence of morin in rats.
Hong SS; Jin MJ; Han HK
Biopharm Drug Dispos; 2008 May; 29(4):189-93. PubMed ID: 18240155
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of poor oral bioavailability of flavonoid Morin in rats: From physicochemical to biopharmaceutical evaluations.
Li J; Yang Y; Ning E; Peng Y; Zhang J
Eur J Pharm Sci; 2019 Feb; 128():290-298. PubMed ID: 30557605
[TBL] [Abstract][Full Text] [Related]
14. Enhanced nimodipine bioavailability after oral administration of nimodipine with morin, a flavonoid, in rabbits.
Choi JS; Burm JP
Arch Pharm Res; 2006 Apr; 29(4):333-8. PubMed ID: 16681041
[TBL] [Abstract][Full Text] [Related]
15. Effects of silybinin, CYP3A4 and P-glycoprotein inhibitor in vitro, on the bioavailability of loratadine in rats.
Li C; Lee MY; Choi JS
Pharmazie; 2010 Jul; 65(7):510-4. PubMed ID: 20662320
[TBL] [Abstract][Full Text] [Related]
16. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
Cho YA; Lee W; Choi JS
Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.
Choi JS; Kang KW
Arch Pharm Res; 2008 Dec; 31(12):1631-6. PubMed ID: 19099234
[TBL] [Abstract][Full Text] [Related]
18. Effects of myricetin on the bioavailability of carvedilol in rats.
Lee W; Woo ER; Choi JS
Pharm Biol; 2012 Apr; 50(4):516-22. PubMed ID: 22132944
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Shin SC; Choi JS; Li X
Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
[TBL] [Abstract][Full Text] [Related]
20. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
Lee CK; Choi JS
Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
